Company Filing History:
Years Active: 1992-1993
Title: Innovations by Raymond Kempenners in Bioreactive Materials
Introduction
Raymond Kempenners is a notable inventor based in Mol, Belgium. He has made significant contributions to the field of bioreactive materials, particularly in the development of prostheses and dental implants. With a total of two patents to his name, Kempenners has focused on creating materials that enhance the integration of implants with bone tissue.
Latest Patents
Kempenners' latest patents include innovative bioreactive materials designed for prostheses and composite implants. One patent describes a sintered, shaped long-life dental implant or osseous prosthesis that chemically bonds to bone tissue. This implant is created through the sintering of bioglass particles, resulting in a material with a specific composition that includes 5-14% Na₂O, 0-12% P₂O₅, 49-57% SiO₂, and a maximum of 33% CaO+CaF₂. The bioreactive material exhibits limited reactivity with bone tissue and a coefficient of expansion less than 10⁻⁵ K⁻¹ from 0°C to 100°C. Another patent outlines a method for preparing an improved bioreactive material that can be welded to bone tissue through chemical bonding. This method involves a series of steps including melting, homogenizing, and cooling a mixture of powders to create a non-crystallized glass.
Career Highlights
Kempenners is associated with S.A. FBFC International, where he continues to innovate in the field of bioreactive materials. His work has the potential to significantly improve the success rates of dental and bone implants, making them more effective and durable.
Collaborations
Kempenners has collaborated with notable professionals in his field, including Paul Ducheyne and Louis Van Hove. These collaborations have likely contributed to the advancement of his research and the successful development of his patented materials.
Conclusion
Raymond Kempenners is a pioneering inventor whose work in bioreactive materials is shaping the future of prosthetics and dental implants. His innovative patents reflect a commitment to improving medical technology and enhancing patient outcomes.